# Kroll Restructuring

Type: Company

Source: GetYourBrief — https://getyourbrief.com/entity/kroll-restructuring
Canonical HTML page: https://getyourbrief.com/entity/kroll-restructuring

## Timeline

- **2026-07-07**: Court Orders $46.75 Million Payout — A California bankruptcy judge rules that Chrome Holding must pay $46.75 million to breach victims, to be distributed by Kroll Restructuring within five business days.
- **2026-07-07**: Court Orders $46.75 Million Payout — A California bankruptcy judge rules that Chrome Holding must pay $46.75 million to breach victims, to be distributed by Kroll Restructuring within five business days.
- **2025-03**: 23andMe Files for Bankruptcy — Citing mounting legal liabilities and declining consumer trust, 23andMe files for Chapter 11 protection in U.S. bankruptcy court.
- **2025-03**: 23andMe Files for Bankruptcy — Citing mounting legal liabilities and declining consumer trust, 23andMe files for Chapter 11 protection in U.S. bankruptcy court.
- **2025**: Bankruptcy Auction Won by Chrome Holding — Anne Wojcicki's Chrome Holding (operating as TTAM Research Institute) wins 23andMe's core assets with a $305 million bid.
- **2025**: Bankruptcy Auction Won by Chrome Holding — Anne Wojcicki's Chrome Holding (operating as TTAM Research Institute) wins 23andMe's core assets with a $305 million bid.
- **2023-10**: 23andMe Data Breach — Hackers use credential stuffing to access 14,000 accounts, leveraging the DNA Relatives feature to ultimately expose the genetic profiles of 6.9 million users.
- **2023-10**: 23andMe Data Breach — Hackers use credential stuffing to access 14,000 accounts, leveraging the DNA Relatives feature to ultimately expose the genetic profiles of 6.9 million users.

## Recent coverage (4 stories, network-wide)

### $46.75M Payout for 6.9M Victims in Genomic Data Breach Bankruptcy Case
2026-07-08 01:15:31 · Sector: legal · Sentiment: Bearish · Impact: 7/10 · Sources: 1

A California bankruptcy judge orders Chrome Holding to compensate 6.9 million consumers affected by the 2023 23andMe breach, creating a landmark ruling on successor liability for privacy harms in asset sales. The settlement, channeled through Kroll Restructuring, tests how courts balance creditor priorities and victim remuneration in digital-age bankruptcies.
Full story: https://getlegalbrief.com/story/23andme-bankruptcy-breach-settlement-legal-precedent

### 6.9M Genetic Profiles Stolen: 23andMe Settlement Forces $47M Health Data Payout
2026-07-08 01:15:24 · Sector: health · Sentiment: Bearish · Impact: 7/10 · Sources: 1

The 23andMe data breach—the largest compromise of genetic health data in history—culminates in a $46.75 million settlement. Healthcare professionals must confront the fallout: exposed predispositions to diseases, detailed ancestry, and the heightened risk of genetic discrimination for millions of patients.
Full story: https://gethealthbrief.com/story/23andme-genetic-data-breach-6-9m-health-payout

### Credential Stuffing to 6.9M Exposures: 23andMe Breach Ends in $47M Penalty
2026-07-08 01:15:15 · Sector: cyber · Sentiment: Bearish · Impact: 7/10 · Sources: 1

The 2023 23andMe attack, which started with simply reusing leaked credentials, ultimately exposed the genetic and health data of 6.9 million users—and now costs $46.75 million. For cybersecurity teams, it is a textbook case of why basic anti‑credential‑stuffing controls and multi‑factor authentication are non‑negotiable for any platform holding sensitive data.
Full story: https://getcyberbrief.com/story/23andme-credential-stuffing-breach-6-9m-payout

### Post-Acquisition Blow: 23andMe Buyer Hit with $47M Genetic Data Breach Fine
2026-07-08 01:15:06 · Sector: bio · Sentiment: Bearish · Impact: 7/10 · Sources: 1

For the biotech world, the 23andMe saga is a stark lesson: acquiring assets out of bankruptcy does not shield from inherited data-breach liabilities. Anne Wojcicki’s $305 million purchase now carries a $46.75 million settlement that could chill future investments in consumer genomics.
Full story: https://getbiobrief.com/story/23andme-acquisition-breach-liability-biotech-valuation

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getyourbrief.com/guides/methodology for the full editorial methodology.